Internet World Congress '98 Invited Symposium

	MAOIs: Mulptiple Effects and Sites of Action Chair: Beth Levant (University of Kansas Medical Center, USA)

0103 MAOIs: Interactions at Dopamine Receptors? B Levant (Dept. of Pharmacology, University of Kansas Medical Center, USA) JD Moehlenkamp (Dept. of Pharmacology, University of Kansas Medical Center, USA) GN Bancroft (Dept. of Pharmacology, University of Kansas Medical Center, USA) KA Morgan (Dept. of Pharmacology, University of Kansas Medical Center, USA)

0398 Neurochemical and Neuroprotective Effect of Aliphatic N-Methylpropargylamine MAO-B Inhibitors. PH Yu (Neuropsychiatry Research Unit, University of Saskatchewan, Canada) X Zhang (Neuropsychiatry Research Unit, University of Saskatchewan, Canada) DM Zuo (Neuropsychiatry Research Unit, University of Saskatchewan, Canada) CT Lai (Neuropsychiatry Research Unit, University of Saskatchewan, Canada) K Tieu (Neuropsychiatry Research Unit, University of Saskatchewan, Canada) BA Davis (Neuropsychiatry Research Unit, University of Saskatchewan, Canada) AA Boulton (Neuropsychiatry Research Unit, University of Saskatchewan, Canada)

0472 The Imidazoline / Guanidinium Binding Domain of Monoamine Oxidase: A Potential, Novel Regulatory Site R Raddatz (Department of Pharmacology, Medical University of South Carolina, USA) S.L. Savic (Department of Pharmacology, Medical University of South Carolina, USA) S.M. Lanier (Department of Pharmacology, Medical University of South Carolina, USA)

0524 Locomotor Sensitization to Quinpirole: Role of a MAOI Sensitive Site K Culver (Department of Psychiatry and Behavioral Neurosciences, McMaster University, Canada) H. Szechtman (Department of Psychiatry and Behavioral Neurosciences, McMaster University, Canada)